Header Logo

Mohit Chopra

Concepts (130)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
4
2025
83
0.710
Why?
Depressive Disorder
3
2009
284
0.710
Why?
Stress Disorders, Post-Traumatic
3
2016
397
0.700
Why?
Opioid-Related Disorders
5
2025
497
0.590
Why?
Memantine
3
2014
23
0.570
Why?
Methadone
3
2025
134
0.570
Why?
Health Status
2
2016
435
0.480
Why?
Excitatory Amino Acid Antagonists
2
2013
37
0.470
Why?
Social Stigma
1
2016
73
0.470
Why?
Obsessive-Compulsive Disorder
1
2011
36
0.370
Why?
Patient Acceptance of Health Care
1
2016
477
0.360
Why?
Benzodiazepines
1
2011
100
0.350
Why?
Narcotics
2
2025
58
0.350
Why?
Disulfiram
2
2025
5
0.320
Why?
Alzheimer Disease
3
2014
721
0.320
Why?
Quality of Life
2
2016
1223
0.310
Why?
Depressive Disorder, Major
3
2011
255
0.310
Why?
Apolipoprotein E4
1
2009
46
0.310
Why?
Antipsychotic Agents
1
2011
301
0.300
Why?
Methadyl Acetate
1
2008
1
0.300
Why?
Reward
1
2009
87
0.300
Why?
Psychiatric Status Rating Scales
2
2013
390
0.300
Why?
Narcotic Antagonists
2
2014
136
0.290
Why?
Naloxone
1
2008
60
0.290
Why?
Buprenorphine
2
2014
191
0.270
Why?
Cognition Disorders
1
2008
217
0.270
Why?
Aging
1
2013
746
0.270
Why?
Alcohol Deterrents
1
2025
6
0.240
Why?
Dementia
1
2008
257
0.240
Why?
Geriatric Assessment
1
2006
163
0.230
Why?
Long-Term Care
1
2006
177
0.230
Why?
Aged
12
2016
14333
0.220
Why?
Male
19
2025
29717
0.220
Why?
Opiate Substitution Treatment
3
2025
205
0.210
Why?
Female
18
2025
32709
0.210
Why?
Hallucinations
1
2003
16
0.200
Why?
Vitamin E
2
2014
53
0.200
Why?
Depression
3
2016
890
0.200
Why?
Treatment Refusal
1
2003
56
0.200
Why?
Mental Competency
1
2003
61
0.200
Why?
Anxiety
3
2016
423
0.190
Why?
Comorbidity
3
2016
1118
0.190
Why?
Informed Consent
1
2003
140
0.190
Why?
Antioxidants
2
2014
252
0.180
Why?
Attitude to Health
1
2003
289
0.170
Why?
Humans
21
2025
63152
0.160
Why?
Nursing Homes
1
2006
666
0.160
Why?
Decision Making
1
2003
407
0.150
Why?
Double-Blind Method
6
2025
737
0.140
Why?
Severity of Illness Index
5
2014
1543
0.140
Why?
Veterans
3
2016
764
0.130
Why?
Dose-Response Relationship, Drug
3
2025
860
0.130
Why?
Cyclohexanecarboxylic Acids
1
2014
9
0.110
Why?
Dopamine Agents
1
2014
11
0.110
Why?
Amines
1
2014
30
0.110
Why?
Sertraline
1
2014
58
0.110
Why?
gamma-Aminobutyric Acid
1
2014
75
0.110
Why?
Aged, 80 and over
4
2014
5429
0.100
Why?
Alcohol-Related Disorders
1
2013
37
0.100
Why?
Alcoholism
1
2016
318
0.100
Why?
Adult
8
2025
16736
0.100
Why?
Longitudinal Studies
2
2013
1254
0.100
Why?
Motivation
1
2014
285
0.090
Why?
Disease Progression
2
2014
1166
0.090
Why?
Combat Disorders
1
2011
11
0.090
Why?
Patient Compliance
2
2014
360
0.090
Why?
Activities of Daily Living
2
2014
291
0.090
Why?
Life Change Events
1
2011
66
0.090
Why?
Internet
1
2014
469
0.090
Why?
Wounds and Injuries
1
2013
247
0.080
Why?
Amphetamine-Related Disorders
1
2009
12
0.080
Why?
Methamphetamine
1
2009
26
0.080
Why?
Chronic Disease
1
2013
752
0.080
Why?
Directive Counseling
1
2009
39
0.080
Why?
Arkansas
1
2008
4
0.080
Why?
Benzhydryl Compounds
1
2009
51
0.080
Why?
Cocaine
2
2025
101
0.070
Why?
Logistic Models
2
2011
1274
0.070
Why?
Secondary Prevention
1
2009
163
0.070
Why?
United States
3
2013
7827
0.070
Why?
Self Concept
1
2008
111
0.070
Why?
Paroxetine
2
2004
16
0.070
Why?
Middle Aged
6
2025
17480
0.070
Why?
Substance Withdrawal Syndrome
1
2008
123
0.070
Why?
Sex Characteristics
1
2008
203
0.070
Why?
Neuropsychological Tests
1
2008
391
0.060
Why?
Psychometrics
1
2008
375
0.060
Why?
Multivariate Analysis
1
2008
934
0.060
Why?
Mental Health Services
2
2011
287
0.060
Why?
Dysthymic Disorder
1
2005
8
0.060
Why?
Psychotherapy
1
2006
97
0.060
Why?
Mortality
1
2006
160
0.060
Why?
Pindolol
1
2004
2
0.060
Why?
Prolactin
1
2004
40
0.060
Why?
Antidepressive Agents
1
2006
225
0.050
Why?
Antidepressive Agents, Second-Generation
1
2004
30
0.050
Why?
Tryptophan
1
2004
57
0.050
Why?
Disability Evaluation
1
2005
217
0.050
Why?
Treatment Outcome
3
2025
5625
0.050
Why?
Combined Modality Therapy
2
2014
371
0.050
Why?
Adrenergic beta-Antagonists
1
2004
150
0.050
Why?
Cross-Sectional Studies
2
2011
2571
0.050
Why?
Hydrocortisone
1
2004
193
0.050
Why?
Drug Therapy, Combination
2
2014
463
0.050
Why?
Surveys and Questionnaires
1
2008
2673
0.040
Why?
Follow-Up Studies
1
2005
2451
0.040
Why?
Primary Health Care
1
2005
690
0.040
Why?
Adolescent
1
2009
6229
0.040
Why?
Remission Induction
2
2011
147
0.030
Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2011
120
0.030
Why?
Retrospective Studies
1
2008
6595
0.030
Why?
GABA Agonists
1
2014
4
0.030
Why?
Diagnosis, Dual (Psychiatry)
1
2014
85
0.030
Why?
Cross-Over Studies
2
2004
161
0.030
Why?
Cholinesterase Inhibitors
1
2014
47
0.030
Why?
Residence Characteristics
1
2014
220
0.020
Why?
Medication Adherence
1
2014
202
0.020
Why?
Recurrence
1
2014
639
0.020
Why?
Risk Factors
2
2011
5331
0.020
Why?
Caregivers
1
2014
270
0.020
Why?
Analgesics, Opioid
1
2014
534
0.020
Why?
Self Report
1
2010
374
0.020
Why?
Sex Factors
1
2011
978
0.020
Why?
Alcohol Drinking
1
2010
314
0.020
Why?
Pilot Projects
1
2009
1004
0.020
Why?
Mass Screening
1
2011
688
0.020
Why?
Fluoxetine
1
2004
44
0.010
Why?
Young Adult
1
2014
4673
0.010
Why?
Drug Administration Schedule
1
2004
298
0.010
Why?
Substance-Related Disorders
1
2011
732
0.010
Why?
Chopra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (130)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_